Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses.

[1]  R. Kim,et al.  Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study. , 2021, European heart journal.

[2]  R. Kim,et al.  Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity , 2021, Journal of Cardiovascular Magnetic Resonance.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  R. Kim,et al.  Epicardial Surface Area of Infarction , 2021, Circulation. Cardiovascular imaging.

[5]  D. Pennell,et al.  SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance , 2020, Journal of Cardiovascular Magnetic Resonance.

[6]  P. Li,et al.  Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma , 2020, BMC Cancer.

[7]  R. Kim,et al.  Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer‐Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole‐Body Positron Emission Tomography , 2019, Journal of the American Heart Association.

[8]  R. Blankstein,et al.  Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes , 2019, Journal of the American Heart Association.

[9]  Hyun Min Jeon,et al.  Regulation of Tumor Progression by Programmed Necrosis , 2018, Oxidative medicine and cellular longevity.

[10]  Jiwon Kim,et al.  Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer , 2017, Journal of Cardiovascular Magnetic Resonance.

[11]  C. Peskin,et al.  Echocardiographic Linear Dimensions for Assessment of Right Ventricular Chamber Volume as Demonstrated by Cardiac Magnetic Resonance. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  Jiwon Kim,et al.  Pattern and Prognostic Implications of Cardiac Metastases Among Patients With Advanced Systemic Cancer Assessed With Cardiac Magnetic Resonance Imaging , 2016, Journal of the American Heart Association.

[13]  V. Fuster,et al.  Value of CMR for the differential diagnosis of cardiac masses. , 2014, JACC. Cardiovascular imaging.

[14]  I. Pedrosa,et al.  Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. , 2014, Clinical genitourinary cancer.

[15]  P. Kellman,et al.  A quantitative pixel-wise measurement of myocardial blood flow by contrast-enhanced first-pass CMR perfusion imaging: microsphere validation in dogs and feasibility study in humans. , 2012, JACC. Cardiovascular imaging.

[16]  R. Kim,et al.  LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. , 2011, JACC. Cardiovascular imaging.

[17]  Manesh R. Patel,et al.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.

[18]  E. Nagel,et al.  Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[19]  J. Min,et al.  Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. , 2009, JACC. Cardiovascular imaging.

[20]  N. Codella,et al.  Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy , 2008, Journal of hypertension.

[21]  R. Kim,et al.  Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. , 2008, Journal of the American College of Cardiology.

[22]  A. Abbate,et al.  Cardiac metastases , 2006, Journal of Clinical Pathology.

[23]  P. Rehak,et al.  Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. , 2006, The Journal of urology.

[24]  Richard D. White,et al.  Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. , 2006, American heart journal.

[25]  Michael T. Lotze,et al.  Inflammation and necrosis promote tumour growth , 2004, Nature Reviews Immunology.

[26]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[27]  Donna Richardson,et al.  Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. , 2002, Lung cancer.

[28]  L D Buadu,et al.  Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. , 1996, Radiology.

[29]  K. Tominaga,et al.  The incidence of secondary tumors of the heart and pericardium: a 10-year study. , 1988, Japanese journal of clinical oncology.

[30]  S. Hanfling,et al.  Metastatic Cancer to the Heart: Review of the Literature and Report of 127 Cases , 1960, Circulation.

[31]  V. Reddy,et al.  Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. , 1990, The American journal of cardiovascular pathology.